22 related articles for article (PubMed ID: 25208013)
1. Radiation Safety and External Radiation Exposure Rate of Patients Receiving I-131 Therapy for Hyperthyroidism and Remnant Ablation as Outpatient: An Institutional Experience.
Bhatia N; Dhingra VK; Mittal P; Saini S
World J Nucl Med; 2023 Sep; 22(3):203-207. PubMed ID: 37854087
[No Abstract] [Full Text] [Related]
2. Assessment of Radiation Exposure in a Nuclear Medicine Department during
Marshall SK; Prom-On P; Sangkue S; Thiangsook W
Toxics; 2023 Sep; 11(10):. PubMed ID: 37888665
[TBL] [Abstract][Full Text] [Related]
3. Calculating radiation exposures during use of (14)C-labeled nutrients, food components, and biopharmaceuticals to quantify metabolic behavior in humans.
Kim SH; Kelly PB; Clifford AJ
J Agric Food Chem; 2010 Apr; 58(8):4632-7. PubMed ID: 20349979
[TBL] [Abstract][Full Text] [Related]
4. The study of external dose rate and retained body activity of patients receiving 131I therapy for differentiated thyroid carcinoma.
Zhang H; Jiao L; Cui S; Wang L; Tan J; Zhang G; He Y; Ruan S; Fan S; Zhang W
Int J Environ Res Public Health; 2014 Oct; 11(10):10991-1003. PubMed ID: 25337944
[TBL] [Abstract][Full Text] [Related]
5. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
[TBL] [Abstract][Full Text] [Related]
6. [A study on the isolation period of patients with metastatic thyroid cancer treated by 131I according to a new guideline].
Tsuchimochi S; Nakajo M; Umanodan T; Fukushima N; Shigaki S; Kiku T
Kaku Igaku; 2001 Nov; 38(6):747-54. PubMed ID: 11806086
[TBL] [Abstract][Full Text] [Related]
7. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
8. Radiation exposure rate from 131I-treated hyperthyroid patients--a dynamic study, with data for up to 42 d post therapy.
Mohammadi H
Health Phys; 2005 May; 88(5):486-90. PubMed ID: 15824597
[TBL] [Abstract][Full Text] [Related]
9. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism.
Matheoud R; Reschini E; Canzi C; Voltini F; Gerundini P
Med Phys; 2004 Dec; 31(12):3194-200. PubMed ID: 15651602
[TBL] [Abstract][Full Text] [Related]
10. Estimating radiation absorbed dose of individuals nearby 131I-treated hyperthyroid patients.
Cui S; Jiao L; Tan J; Zhang G; Zhang H; Long W; Fan S; Zhang W
Health Phys; 2014 Mar; 106(3):365-9. PubMed ID: 25208013
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse.
Greaves C; Tindale W
J Radiol Prot; 2001 Dec; 21(4):381-92. PubMed ID: 11787894
[TBL] [Abstract][Full Text] [Related]
12. Patient release criteria following radioactive iodine-131 treatment in the light of international practice: where does South Africa fit in?
Mongane MS; Rae WID
Nucl Med Commun; 2017 Oct; 38(10):805-809. PubMed ID: 28727659
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
